Term
|
Definition
|
|
Term
|
Definition
| Smooth Muscle Movement, Coordination |
|
|
Term
|
Definition
| Contains cells that produce neurotransmitters |
|
|
Term
|
Definition
| Produces Dopamine, death causes parkinson's, releases on Basal Ganglia |
|
|
Term
|
Definition
| produces dopamine onto limbic area |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Emotion, Thought, Learning, Memory |
|
|
Term
|
Definition
| Emotion, Thought, Learning, Memory |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Anti-psychotic, ADHD, mixture of amphetamine salts |
|
|
Term
|
Definition
| Anti-psychotic, ADHD, DAT blocker |
|
|
Term
|
Definition
| Anti-psychotic, ADHD, NET inhibitor |
|
|
Term
|
Definition
| Anti-psychotic, ADHD, NET inhibitor |
|
|
Term
|
Definition
| Anti-psychotic, ADHD, DAT/NET weak inhibitor |
|
|
Term
|
Definition
| Anti-psychotic, ADHD, Cheaper because only active isoform |
|
|
Term
|
Definition
| Anti-psychotic, ADHD, Lysine prodrug to prevent abuse |
|
|
Term
|
Definition
| Anti-psychotic, ADHD, a2 agonist, used when others are intolerated |
|
|
Term
|
Definition
| Anti-psychotic, anorexic, Act like amphetamine |
|
|
Term
|
Definition
| Anti-psychotic, anorexic, Act like amphetamine |
|
|
Term
|
Definition
| Anti-psychotic, anorexic, Act like amphetamine |
|
|
Term
|
Definition
| Anti-psychotic, anorexic, effective, increase in stroke |
|
|
Term
|
Definition
| Anti-psychotic, anorexic, NET/DAT inhibitor, prodrug, not effective |
|
|
Term
|
Definition
| Caused by death of substantia negra |
|
|
Term
|
Definition
| Symptoms of tremors and lack of controlled movement |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Taken with L-DOPA to act peripherally as a decarboxylase inhibitor |
|
|
Term
|
Definition
| Dopamine Agonist, Parkinson's, D1/D2 nonselective, non-oral |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Parkinson's D2 agonist, restless leg syndrome |
|
|
Term
|
Definition
| Parkinson's D2 agonist, Hyperprolactemia |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Parkinson's COMT inhibitor |
|
|
Term
|
Definition
| Parkinson's Antimuscarinic |
|
|
Term
|
Definition
| Parkinson's antimuscarinic |
|
|
Term
|
Definition
| 5HT2A agonists, cause hallucinations, have tachyphillaxis |
|
|
Term
|
Definition
| Pyscadelic phenylethylamine, ceremonial |
|
|
Term
|
Definition
| Pyscadelic Tryptamine, Shrooms |
|
|
Term
|
Definition
| Pyscadelic Tryptamine, ceremonial, can be combined with MAOI to increase effect |
|
|
Term
|
Definition
| Pyscadelic phenylethylamine |
|
|
Term
|
Definition
| Pyscadelic phenylethylamine, used for research purposes |
|
|
Term
|
Definition
| Pyscadelic ergoline, most potent hallucinogen, diethylamine makes it potent |
|
|
Term
|
Definition
| Entactogenic Psychedelic, can cause serotonin syndrome |
|
|
Term
|
Definition
| Hyperthermia that can be fatal following extacy |
|
|
Term
|
Definition
| CB1/2 Agonist, CB most prevalent receptor in brain, GPCR-Gi coupled |
|
|
Term
|
Definition
| Dissociative psychedelic, NMDA antagonist |
|
|
Term
|
Definition
| Treatment w/ D2 antagonists |
|
|
Term
|
Definition
|
|
Term
| 5HT2A Antagonist Symptoms |
|
Definition
| Negative Symptoms, weight gain, diabetes |
|
|
Term
|
Definition
|
|
Term
| Malignant Neuroleptic Syndrome |
|
Definition
| symptoms of EPS, fatal, treat with diazepame |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Typical Schiz drug with high EPS |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Non-schiz typical used to treat nausea and vomiting |
|
|
Term
|
Definition
| Non-schiz typical to treat Tourrette's |
|
|
Term
|
Definition
| Atypical Schiz causing agranulocytosis |
|
|
Term
|
Definition
| Atypical Schiz, bioisostere of clozapine, increased diabetes |
|
|
Term
|
Definition
| Atypical Schiz, actually designed to antagonize 5HT2A and D2 |
|
|
Term
|
Definition
| Atypical Schiz prolongs QT interval |
|
|
Term
|
Definition
| Atypical Schiz, partial D2/5HT2A agonist, also used for depression |
|
|
Term
|
Definition
| Act as transport inhibitors |
|
|
Term
|
Definition
| Anti-Depressant,Irreversible MAOI-A/B Inhibitor |
|
|
Term
|
Definition
| Anti-Depressant,Irreversible MAOI-A/B Inhibitor |
|
|
Term
|
Definition
| Anti-Depressant,Irreversible MAOI-A/B Inhibitor |
|
|
Term
|
Definition
| Anti-Depressant,Reversible MAOI-A Inhibitor |
|
|
Term
|
Definition
| TCA's- NET/SERT inhibitors |
|
|
Term
| Amitriptyline/ Nortrytyline |
|
Definition
| TCA's- NET/SERT inhibitor |
|
|
Term
| Doxapine, Trimipramine, Clonipramine |
|
Definition
| TCA's- last causing orgasm when yawning |
|
|
Term
|
Definition
|
|
Term
| Fluoxitine, Fluvoxitine, Paroxitine, Sertraline, Citalopram |
|
Definition
|
|
Term
|
Definition
| 5HT2A selective antagonist for depression |
|
|
Term
|
Definition
| 5HT2A and a2 antagonist, least sexual side effects |
|
|
Term
|
Definition
| Blocks all transporters but DAT selective to treat depression and smoking cessation |
|
|
Term
| Dual Inhibitors(SNRI's) action |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Net Inhibitors to treat depression |
|
|
Term
|
Definition
| NSRI's used to treat depression and also pain |
|
|
Term
|
Definition
| First used to treat Bi-polar, small therapeutic window |
|
|
Term
|
Definition
| Na blockers, anti-convulsive, 1st line for bi-polar |
|
|
Term
|
Definition
| Used dually in bi-polar to treat both mania and depression |
|
|
